Cargando…
Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
Nearly half of the people suffering from schizophrenia also present with a lifetime history of substance use disorders (SUD), a rate that is much higher than the one seen among unaffected individuals. This phenomenon suggests that the factors influencing SUD risk in schizophrenia may be more numerou...
Autor principal: | Volkow, Nora D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669586/ https://www.ncbi.nlm.nih.gov/pubmed/19325163 http://dx.doi.org/10.1093/schbul/sbp016 |
Ejemplares similares
-
Morbidity and mortality in schizophrenia with comorbid substance use disorders
por: Lähteenvuo, Markku, et al.
Publicado: (2021) -
Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021) -
Research on substance use disorders during the COVID-19 pandemic()
por: Volkow, Nora D., et al.
Publicado: (2021) -
Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
por: Lähteenvuo, M., et al.
Publicado: (2021) -
Demographic and Clinical Correlates of Substance Abuse Comorbidity in Schizophrenia
por: Aich, Tapas K., et al.
Publicado: (2004)